Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CERS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
METTL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDCCAG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HKR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMG7-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ABCB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF214 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101926921 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF229 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on